Back
CRISPR Therapeutics AG Stock Price Chart
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Sell
40
CRSP
CRISPR Therapeutics AG
Last Price:
55.61
Seasonality Move:
22.82%
7 Day Trial
ALL ACCESS PASS
$
7
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.4 | Sell |
| 20-day SMA: | 61.49 | Sell |
| 50-day SMA: | 71.78 | Sell |
| 200-day SMA: | 59.5 | Sell |
| 8-day EMA: | 57.06 | Sell |
| 20-day EMA: | 61.2 | Sell |
| 50-day EMA: | 66.13 | Sell |
| 200-day EMA: | 62.68 | Sell |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.4 | Sell |
| Relative Strength Index (14 RSI): | 28.82 | Sell |
| Chaikin Money Flow: | -790956 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.6 - 69.68) | Sell |
| Bollinger Bands (100): | (59.93 - 76.41) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 55.65 while CRSP 8-day simple moving average is 56.40, which is a Sell signal.
- The stock price of CRSP is 55.65 while CRISPR Therapeutics AG 20-day SMA is 61.49, which makes it a Sell.
- CRISPR Therapeutics AG 50-day simple moving average is 71.78 while CRSP share price is 55.65, making it a Sell technically.
- CRSP stock price is 55.65 and CRISPR Therapeutics AG 200-day simple moving average is 59.50, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
40
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a Sell
The current CRISPR Therapeutics AG [CRSP] share price is $55.65. The Score for CRSP is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
4.72B
Price in USD:
55.65
Share Volume:
910.8K
CRISPR Therapeutics AG 52-Week Range
52-Week High:
91.10
52-Week Low:
37.55
Sell
40
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?
The CRISPR Therapeutics AG stock price is 55.65 USD today. -
Will CRSP stock go up or go down?
CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators -
Is CRISPR Therapeutics AG overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 55.65 while CRSP 8-day exponential moving average is 57.06, which is a Sell signal.
- The stock price of CRSP is 55.65 while CRISPR Therapeutics AG 20-day EMA is 61.20, which makes it a Sell.
- CRISPR Therapeutics AG 50-day exponential moving average is 66.13 while CRSP share price is 55.65, making it a Sell technically.
- CRSP stock price is 55.65 and CRISPR Therapeutics AG 200-day simple moving average is 62.68, creating a Sell signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
- Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.19 per share, a decrease this year of $2.60 per share, and an increase next year of $1.51 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
- CRSP Moving Average Covergence Divergence (MACD) indicator is -4.4, suggesting CRISPR Therapeutics AG is a Sell
- CRISPR Therapeutics AG Relative Strength Index (RSI) is 28.82, which suggest CRISPR Therapeutics AG is oversold
- The Bollinger Bands (25) for CRISPR Therapeutics AG is (57.6 - 69.68), which suggest CRISPR Therapeutics AG is a Sell
- The Bollinger Bands (100) for CRISPR Therapeutics AG is (59.93 - 76.41), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.